Poor patients in Punjab will have access to high-quality medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access
Punjab government will make medicines available free of charge through public sector hospitals from early 2018 onward
Pakistan is among the countries most affected by chronic diseases; more than half of its population lives in the Punjab province
Article
Poor patients in Punjab will have access to high-quality medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access
Punjab government will make medicines available free of charge through public sector hospitals from early 2018 onward
Pakistan is among the countries most affected by chronic diseases; more than half of its population lives in the Punjab province
The Novartis Foundation and the University of Basel, together with other partners are pleased to announce the launch of Healthy Schools for Healthy Communities. The initiative aims to address poor health in disadvantaged schools in South Africa.
Article
The Novartis Foundation and the University of Basel, together with other partners are pleased to announce the launch of Healthy Schools for Healthy Communities. The initiative aims to address poor health in disadvantaged schools in South Africa and is the first Novartis Foundation program to include the education sector, bringing new opportunities for achieving impact.
Novartis reaches agreement with Cameroon to supply medicines against chronic diseases for the poorest populations
Summary:
Novartis reaches agreement with Cameroon to supply medicines against chronic diseases for the poorest populations
Cameroon Baptist Convention Health Services have started distributing medicines in selected parts of the country; capacity-building activities to kick off this month
Cameroon becomes the sixth country to launch Novartis Access
Press Release
Novartis reaches agreement with Cameroon to supply medicines against chronic diseases for the poorest populations
Cameroon Baptist Convention Health Services have started distributing medicines in selected parts of the country; capacity-building activities to kick off this month
Cameroon becomes the sixth country to launch Novartis Access
On World Heart Day 2017, the Novartis Foundation and our partners are proud to report the ambitious steps we are taking around the world to tackle hypertension in low- and middle-income countries (LMICs).
Article
Cardiovascular diseases, including hypertension, account for nearly half of the world’s deaths from non-communicable diseases (NCDs).[1] With almost 75% of NCD deaths occurring in LMICs,[2] the Novartis Foundation recognizes the importance of World Heart Day in raising awareness of cardiovascular disease and promoting good heart health globally.
The Novartis Foundation is pleased to announce IntraHealth International and PATH as local implementation partners for the Better Hearts Better Cities initiative in Dakar, Senegal.
Compound has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission
KAF156 is first compound from the imidazolopiperazines, a novel class of antimalarials, to enter phase IIb combination studies
Clinical trial has started early August in adults with malaria and is planned to expand to adolescents and children in a total of nine countries in Africa and Asia
As World Mosquito Day approaches, revisit this story from the Novartis archives about healthcare worker Dismus Mwalukwanda who’s on the front line in the battle against malaria in Zambia.
Article
Healthcare worker Dismus Mwalukwanda is on the front line of the battle against malaria. Saving lives is his priority
As World Mosquito Day approaches, revisit this story from the Novartis archives on how the rising concern of resistance threatens the great progress made against malaria
Article
In Kenya, about three-quarters of the population is at risk for malaria, and all four species of the malaria parasite that infect humans occur in the country. Although there has been substantial progress, malaria remains the leading cause of mortality in Kenya, killing an estimated 30,000 people every year, most of them children under 5 years old.
As World Mosquito Day approaches, revisit this story from the Novartis archives celebrating the hard work done by Agnes Akoth to fight against malaria in Kenya.
Article
In Kenya, about three-quarters of the population is at risk for malaria, and all four species of the malaria parasite that infect humans occur in the country. Although there has been substantial progress, malaria remains the leading cause of mortality in Kenya, killing an estimated 30,000 people every year, most of them children under 5 years old.
